ECO Animal Health participating at Animal Health, Nutrition and Technology Innovation summit

ECO Animal Health Group plc (LON:EAH) has announced its results for the six months ended 30 September 2022. HIGHLIGHTS Financials ·    Group Sales at £34.9 million (H1 2021: £38.5 million) –  China and Japan sales declined to £8.5 million (H1

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that David Hallas, CEO, and Christopher Wilks, CFO, will be conducting a live presentation

Following a competitive tender process overseen by the Group’s Audit & Risk Committee, ECO Animal Health Group (LON:EAH) has announced the resignation of BDO LLP as auditor and the appointment, with immediate effect, of Haysmacintyre LLP as auditor for the

ECO Animal Health Group plc (LON:EAH) has announced the publication of the following documents on the Company’s website: www.ecoanimalhealthgroupplc.com/investor-relations.aspx. ·     Annual Report and Accounts for the year ended 31 March 2022 ·    Notice of Annual General Meeting to be held

ECO Animal Health Group plc (LON:EAH) has announced its results for the year ended 31 March 2022. HIGHLIGHTS Financials ·      Group sales down 22% at £82.2m (2021: £105.6m) – China and Japan sales declined significantly to £28.4m (2021: £58.9m) – ROW

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has provided an update to its expected results for the year ended 31 March 2022.  The audit

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has signed a new bank facility agreement with its bank, National Westminster Bank

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that its wholly owned subsidiary, ECO Animal Health Ltd, has entered into a research partnership

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that its wholly owned subsidiary, ECO Animal Health Ltd, has entered into a research partnership

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, states that it has been notified that on 31 March 2022, Christopher Wilks, Chief Financial Officer, purchased

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets has provided an unaudited trading update for the financial year ending 31st March 2022. ECO commented in

ECO Animal Health Group plc (LON:EAH) has announced that its subsidiary ECO Animal Health Limited has received two marketing authorisations from the Ministry of Agriculture and Rural Affairs of the People’s Republic of China for the use of

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that Marc Loomes, CEO, Christopher Wilks, CFO, and Hafid Benchaoui, Global Head of R&D, will be

ECO Animal Health Group plc (LON:ECO), a leader in the development, registration and marketing of pharmaceutical products for the global animal health market, has announced that the Board of the Company has approved David Hallas’s appointment as Chief Executive Officer

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health market has provided an update on its operations in China. The pork price in China has increased from

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health market, is pleased to announce the appointment of Tracey James as a Non-Executive Director with immediate effect. Tracey